Citenamide
CAS No. 10423-37-7
Citenamide( —— )
Catalog No. M33319 CAS No. 10423-37-7
Citenamide (AY-15613) has anticancer and anticonvulsant activity and is used in the study of neurological disorders because of its sleep-promoting properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 219 | In Stock |
|
| 10MG | 370 | In Stock |
|
| 25MG | 718 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCitenamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionCitenamide (AY-15613) has anticancer and anticonvulsant activity and is used in the study of neurological disorders because of its sleep-promoting properties.
-
DescriptionCitenamide is an anticonvulsant.
-
In Vitro——
-
In VivoCitenamide (Cytenamide, CYT) is an analogue of Carbamazepine (CBZ), a dibenzazepine drug used to control seizures.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number10423-37-7
-
Formula Weight235.28
-
Molecular FormulaC16H13NO
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(N)C1C=2C=CC=CC2C=CC=3C=CC=CC31
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Cefuroxime
Cefuroxime (Standard) is the analytical standard of Cefuroxime. This product is intended for research and analytical applications. Cefuroxime is an orally active second-generation cephalosporin antibiotic with increased stability to β-lactamase. Cefuroxime has a broad spectrum activity against Gram-positive and Gram-negative bacteria.
-
2-heptyl-3-hydroxy-4...
2-heptyl-3-hydroxy-4(1H)-Quinolone (Pseudomonas Quinolone Signal) is a quorum-sensing signalling molecule produced by Pseudomonas aeruginosa in response to increased cell density.
-
Setrobuvir
Setrobuvir (ANA-598) is an orally active non-nucleoside HCV NS5B polymerase inhibitor with inhibitory effects on de novo RNA synthesis and primer extension with IC50s between 4 and 5 nM.
Cart
sales@molnova.com